No black box warning on record for Hyperactivity-Mental Focus
As of the latest FDA labeling reviewed, Hyperactivity-Mental Focus (ADRENALINUM, ACONITUM NAP., ARG. NIT., ARSENICUM ALB., BAPTISIA, CHAMOMILLA, CYPRIPEDIUM, DIGITALIS, GELSEMIUM, HUMULUS, IGNATIA, IMPATIENS GLANDULIFERA FLOS, IODIUM, LACHESIS, LYCOPODIUM, NAT. MUR., NUX VOM., SCUTELLARIA LATERIFLORA, STAPHYSAG., STRAMONIUM, THERIDION, ECHINACEA, GINGKO, HYPERICUM, PASSIFLORA) does not carry a black box warning. Standard warnings and precautions still apply — see the full Hyperactivity-Mental Focus medicine page for the complete safety profile.